Autonomic Nervous System Drugs Practice Questions

Q: What is the preferred preoperative drug for managing blood pressure in a patient with pheochromocytoma?

Phenoxybenzamine. ***Phenoxybenzamine***- It is the standard first-line agent, administered 10–14 days preoperatively, because it is a **non-selective**, **irreversible alpha-adrenergic blocker**.- This irreversible blockade prevents the high concentrations of circulating **catecholamines** (epinephrine and norepinephrine) resulting in severe **hypertensive crisis** during surgical tumor manipulation.*Propranolol*- Propranolol and other pure **beta-blockers** should only be initiated *after* adequate **alpha-blockade** is established, typically to control tachycardia.- Giving a beta-blocker alone leaves the **alpha-1 receptors** unopposed, leading to unchecked systemic **vasoconstriction** and severe, potentially fatal, hypertension.*Prazosin*- Although Prazosin is an **alpha-1 selective blocker**, it is generally less preferred because it is a *reversible* antagonist.- **Phenoxybenzamine** is favored because its irreversible action provides superior, more stable, and prolonged protection against massive **catecholamine surges** during surgery.*Labetalol*- Labetalol is generally avoided for initial control because its **beta-blocking action** significantly outweighs its alpha-blocking action (high beta:alpha ratio).- This dominant beta blockade can induce **unopposed alpha vasoconstriction**, similar to pure beta-blockers, resulting in paradoxical and severe **hypertension**.

Q: Mechanism of action of botulinum toxin is:

Inhibits the release of acetylcholine. ***Inhibits the release of Acetylcholine***- Botulinum toxin (BoNT) is a **zinc metalloprotease** that cleaves **SNARE proteins** (e.g., SNAP-25) essential for vesicular fusion and neurotransmitter release.- By preventing the exocytosis of **acetylcholine (ACh)** vesicles at the **neuromuscular junction**, BoNT causes irreversible chemical denervation and resulting **flaccid paralysis**.*Inhibits Elongation factor 2*- Inhibition of **Elongation factor 2 (EF-2)** targets the host cell's **protein synthesis** machinery, leading to cell death.- This mechanism is characteristic of toxins like **Diphtheria toxin** and *Pseudomonas aeruginosa* **Exotoxin A**, not botulinum toxin.*Inhibits the release of GABA*- While BoNT can inhibit the release of various neurotransmitters, its defining clinical effect of **flaccid paralysis** is primarily due to inhibition of **acetylcholine** at the peripheral neuromuscular junction.- Inhibition of **GABA** (an inhibitory neurotransmitter) in the CNS would typically lead to increased CNS excitability or spasms, which is contrary to the effects of botulism.*Increases cAMP*- Increasing intracellular **cAMP** levels, usually via activation of **adenylate cyclase**, is the mechanism used by toxins such as **cholera toxin** and **pertussis toxin**.- This mechanism primarily causes large fluid shifts (diarrhea) or cellular dysfunction (like impaired phagocytosis) and is unrelated to botulinum toxin's paralytic action.

Q: A patient came to the hospital with muscle weakness, diarrhea, and bradycardia. He was diagnosed with organophosphate poisoning for which atropine was administered. After atropine administration, which of the following changes are not seen?

Muscle weakness. ***Muscle weakness*** - Muscle weakness in organophosphate poisoning is a **nicotinic effect** caused by excessive acetylcholine at the **neuromuscular junction (NMJ)** - This leads to initial fasciculations followed by depolarization blockade and paralysis - **Atropine is a muscarinic antagonist** and has **no effect on nicotinic receptors** - Therefore, atropine does **not reverse muscle weakness** - this requires **pralidoxime** (2-PAM) to reactivate acetylcholinesterase - Muscle weakness is the change that is **NOT SEEN** after atropine administration *Bradycardia* - Bradycardia is a **muscarinic effect** on the heart (M2 receptors on SA node) - Atropine effectively blocks cardiac muscarinic receptors, leading to **increased heart rate** - This change (reversal of bradycardia) **IS SEEN** with atropine administration *Diaphoresis* - Excessive sweating is mediated by **muscarinic receptors** on eccrine sweat glands - Atropine blocks these receptors, causing **dry skin** (anticholinergic effect) - This change (cessation of sweating) **IS SEEN** with atropine *Nasal discharge* - Rhinorrhea (nasal secretions) is a **muscarinic effect** - part of SLUDGE syndrome - Atropine blocks glandular muscarinic receptors, causing **drying of secretions** - This change (reduction in nasal discharge) **IS SEEN** with atropine **Key Concept**: Atropine reverses only **muscarinic** effects (SLUDGE, bradycardia, bronchospasm) but NOT **nicotinic** effects (muscle weakness, fasciculations). Pralidoxime is needed for nicotinic symptoms.

Q: Which of the following conditions is not reversed with the administration of atropine?

Muscle weakness due to neuromuscular blockade. ***Muscle weakness due to neuromuscular blockade*** - Atropine is a **muscarinic receptor antagonist** and therefore has no direct effect on the **nicotinic receptors** responsible for neuromuscular transmission and muscle strength. - The reversal of **non-depolarizing neuromuscular blockade** requires increasing acetylcholine via a **cholinesterase inhibitor** (e.g., neostigmine), which acts at the **neuromuscular junction**. *Bradycardia* - Atropine blocks **M2 receptors** on the heart's sinoatrial (SA) node, inhibiting **vagal tone** and increasing the heart rate, thereby reversing bradycardia. - It is the primary drug used to treat hemodynamically significant **bradyarrhythmias**. *Excessive salivation* - Atropine is an anticholinergic agent that blocks **M3 receptors** on exocrine glands, effectively reducing all secretions, including **saliva**. - This is why it is often used as a pre-anesthetic agent to dry secretions and reduce the risk of **aspiration**. *Bronchoconstriction* - Atropine blocks **M3 receptors** in the bronchial smooth muscle, leading to relaxation and **bronchodilation**. - While effective, related synthetic compounds like **ipratropium** are often preferred for treating bronchoconstriction due to fewer systemic anticholinergic side effects.

Q: Which drug elicits the following response on blood pressure and heart rate, as shown in the image?

Norepinephrine. ***Norepinephrine*** - Norepinephrine is a potent agonist at **α1** and **β1** receptors with minimal **β2** activity. The strong **α1** stimulation causes intense vasoconstriction, leading to a marked increase in systolic, diastolic, and mean arterial pressure, as seen in the graph. - Although norepinephrine directly stimulates the heart via **β1** receptors, the significant rise in blood pressure activates the **baroreceptor reflex**. This reflex increases vagal tone, which overrides the direct chronotropic effect and results in a net decrease in heart rate (reflex bradycardia). *Isoproterenol* - Isoproterenol is a non-selective **β-agonist** (**β1** and **β2**) and lacks **α-agonist** effects. It would cause a significant increase in heart rate (**β1** effect). - Its potent **β2** receptor stimulation leads to vasodilation and a *decrease* in diastolic and mean arterial pressure, which is the opposite of the response shown. *Epinephrine* - Epinephrine stimulates **α1**, **β1**, and **β2** receptors. At typical doses, the direct **β1** effect increases the heart rate, and the **β2** effect partially counteracts **α1**-mediated vasoconstriction, leading to a smaller rise in diastolic pressure. - The pronounced reflex bradycardia and significant increase in both systolic and diastolic pressure are more characteristic of norepinephrine's lack of **β2** agonism. *Dopamine* - Dopamine's effects are dose-dependent. At pressor doses (high doses) that stimulate **α1** receptors to increase blood pressure, there is also significant **β1** receptor stimulation. - The concurrent **β1** stimulation typically causes tachycardia or prevents significant reflex bradycardia, which is inconsistent with the graph showing a decreased heart rate.

Q: Which of the following statement is correct regarding the mechanism of action of labetalol?

Blocks both alpha and beta-adrenergic receptors.. ***Blocks both alpha and beta-adrenergic receptors*** - Labetalol is a unique **non-selective beta-blocker** (blocking $\beta_1$ and $\beta_2$) that also possesses **selective $\alpha_1$-adrenergic blocking activity**. - This combined mechanism makes it effective for conditions like **hypertensive emergencies**, providing both reduced heart rate (via beta block) and peripheral vasodilation (via alpha block). *Directly acts as arterial vasodilator resulting in indirect effect tachycardia* - While labetalol causes **vasodilation** (due to $\alpha_1$ blockade), it also **blocks $\beta$-receptors**, preventing the typical **reflex tachycardia** that occurs with direct vasodilators like hydralazine. - Its primary mechanism is receptor blockade, not direct smooth muscle relaxation. *Primarily acts as a vasodilator with little effect on arterioles* - Labetalol acts as a potent **arteriolar vasodilator** (via $\alpha_1$ blockade), which is crucial for lowering systemic vascular resistance and blood pressure. - Its vasodilatory effect is significant and targeted at arterioles. *Decreases peripheral vascular resistance by directly acting as a relaxant for vascular smooth muscles* - Labetalol decreases **peripheral vascular resistance (PVR)** through **antagonism of $\alpha_1$ receptors** in vascular smooth muscles, preventing vasoconstriction. - It does not act as a direct smooth muscle relaxant like nitroprusside or hydralazine.

Question 1

Bradycardia is seen with which of the following drugs?

Accepted Answer

Succinylcholine

Answer

Midazolam

Answer

Epinephrine

Answer

Dopamine

Question 2

Metoprolol is preferred over Propranolol as it:

Accepted Answer

Is more potent in blocking beta-1 receptors

Answer

Is more potent in blocking beta-2 receptors

Answer

Is more effective in suppressing essential tremors

Answer

Impairs exercise capacity

Question 3

What is the preferred preoperative drug for managing blood pressure in a patient with pheochromocytoma?

Accepted Answer

Phenoxybenzamine

Answer

Prazosin

Answer

Propranolol

Answer

Labetalol

Question 4

Mechanism of action of botulinum toxin is:

Accepted Answer

Inhibits the release of acetylcholine

Answer

Increases cAMP

Answer

Inhibits the release of GABA

Answer

Inhibits Elongation Factor 2

Question 5

What is the mechanism of action of botulinum toxin?

Accepted Answer

Inhibits acetylcholine release from the presynaptic terminal

Answer

Blocks the postsynaptic acetylcholine receptor

Answer

Inhibits acetylcholine reuptake

Answer

Inhibits acetylcholinesterase

Question 6

A patient came to the hospital with muscle weakness, diarrhea, and bradycardia. He was diagnosed with organophosphate poisoning for which atropine was administered. After atropine administration, which of the following changes are not seen?

Accepted Answer

Muscle weakness

Answer

Nasal discharge

Answer

Bradycardia

Answer

Diaphoresis

Question 7

Which of the following conditions is not reversed with the administration of atropine?

Accepted Answer

Muscle weakness due to neuromuscular blockade

Answer

Bradycardia

Answer

Bronchoconstriction

Answer

Excessive salivation

Question 8

The most appropriate description of the vasomotor reversal of Dale is that

Accepted Answer

A patient pretreated with phentolamine develops severe hypotension on the administration of adrenaline

Answer

Repeated administration of ephedrine decreases its effect on blood pressure

Answer

An increase in pulse pressure is produced by the intravenous administration of isoprenaline

Answer

High dose of acetylcholine after alpha blockade produces vasomotor reversal

Question 9

Which drug elicits the following response on blood pressure and heart rate, as shown in the image?

Accepted Answer

Norepinephrine

Answer

Epinephrine

Answer

Dopamine

Answer

Isoproterenol

Question 10

Which of the following statement is correct regarding the mechanism of action of labetalol?

Accepted Answer

Blocks both alpha and beta-adrenergic receptors.

Answer

Primarily acts as a vasodilator with little effect on arterioles

Answer

Decreases peripheral vascular resistance by directly acting as a relaxant for vascular smooth muscles.

Answer

Directly acts as arterial vasodilator resulting in indirect effect tachycardia.

Autonomic Nervous System Drugs — MCQs

Autonomic Nervous System Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?